Gear Patrol on MSN
The North Face just released what is easily its nicest travel bag ever
Swapping out PVC for leather, this version of the Base Camp Duffel turns the iconic go-anywhere bag into a first-class ...
Starting a TNF inhibitor within 1 year of the onset of back pain may not improve clinical outcomes or drug retention compared ...
Treating inflammatory bowel disease (IBD) with tumor necrosis factor (TNF) inhibitors was paradoxically associated with an increased risk for other immune-mediated inflammatory diseases (IMIDs) in a ...
In this video, Florence-Damilola Oyinola Odufalu, MD, a gastroenterologist and assistant professor of clinical medicine at the University of Southern California Keck School of Medicine, discusses the ...
The availability of TNF inhibitor biosimilars and the cost of treating ‘difficult-to-treat’ RA are making first-line TNF ...
A Janus kinase (JAK) inhibitor outperformed tumor necrosis factor (TNF) blockers for substantially reducing rheumatoid arthritis (RA) symptoms in patients for whom conventional anti-rheumatic drugs ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with axial SpA treated with TNF inhibitors had ...
“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNFA” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results